Atlas Trials

The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea

Clinical trial NCT07343635 · RECRUITING

Trial details

NCT number
NCT07343635
Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Erythematotelangiectatic Rosacea
Start date
2026-02-01
Primary completion
2027-07-01
Enrollment
186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.